問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
邱昭華
下載
2025-08-01 - 2032-03-02
Condition/Disease
Test Drug
Participate Sites5Sites
Recruiting5Sites
2025-10-01 - 2028-12-31
Participate Sites6Sites
Recruiting6Sites
2020-04-01 - 2025-11-26
Participate Sites7Sites
Not yet recruiting2Sites
Recruiting4Sites
Terminated1Sites
2018-08-01 - 2026-12-01
Participate Sites9Sites
Recruiting8Sites
2023-04-01 - 2026-12-31
Not yet recruiting5Sites
Recruiting2Sites
2023-09-30 - 2026-06-30
Participate Sites3Sites
2017-01-01 - 2020-12-31
Participate Sites2Sites
2021-06-01 - 2023-12-31
Participate Sites4Sites
2015-12-10 - 2019-12-31
NON-SMALL CELL LUNG CANCER WHO HAVE BRAIN METASTASES
(1)Avastin; (2) Erlotinib
Recruiting3Sites
2019-04-01 - 2022-12-31
non-squamous non-small cell lung cancer
Durvalumab、Tremelimumab
Participate Sites8Sites
Division of General Internal Medicine
全部
